Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 38212807)

  • 1. Involvement of the tumour necrosis factor receptor system in glioblastoma cell death induced by palbociclib-heptamethine cyanine dye conjugate.
    Cooper E; Oyagawa CRM; Johnson R; Choi PJ; Foliaki JM; Correia J; Schweder P; Heppner P; Mee E; Turner C; Faull R; Denny WA; Dragunow M; Jose J; Park TI
    Cell Commun Signal; 2024 Jan; 22(1):30. PubMed ID: 38212807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elucidating the cellular uptake mechanisms of heptamethine cyanine dye analogues for their use as an anticancer drug-carrier molecule for the treatment of glioblastoma.
    Cooper E; Choi PJ; Hwang K; Nam KM; Kim CY; Shaban T; Schweder P; Mee E; Correia J; Turner C; Faull RLM; Denny WA; Noguchi K; Dragunow M; Jose J; Park TI
    Chem Biol Drug Des; 2023 Mar; 101(3):696-716. PubMed ID: 36323652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytoprotective agent troxipide-cyanine dye conjugate with cytotoxic and antiproliferative activity in patient-derived glioblastoma cell lines.
    Cooper E; Choi PJ; Schweder P; Mee E; Turner C; Faull R; Denny WA; Dragunow M; I-H Park T; Jose J
    Bioorg Med Chem Lett; 2021 Oct; 50():128336. PubMed ID: 34438012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The synthesis of a novel Crizotinib heptamethine cyanine dye conjugate that potentiates the cytostatic and cytotoxic effects of Crizotinib in patient-derived glioblastoma cell lines.
    Choi PJ; Cooper E; Schweder P; Mee E; Faull R; Denny WA; Dragunow M; Park TI; Jose J
    Bioorg Med Chem Lett; 2019 Sep; 29(18):2617-2621. PubMed ID: 31378572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conjugation of Palbociclib with MHI-148 Has an Increased Cytotoxic Effect for Breast Cancer Cells and an Altered Mechanism of Action.
    Choi PJ; Tomek P; Tercel M; Reynisson J; Park TIH; Cooper EA; Denny WA; Jose J; Leung E
    Molecules; 2022 Jan; 27(3):. PubMed ID: 35164144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of DNA damage repair by the CDK4/6 inhibitor palbociclib delays irradiated intracranial atypical teratoid rhabdoid tumor and glioblastoma xenograft regrowth.
    Hashizume R; Zhang A; Mueller S; Prados MD; Lulla RR; Goldman S; Saratsis AM; Mazar AP; Stegh AH; Cheng SY; Horbinski C; Haas-Kogan DA; Sarkaria JN; Waldman T; James CD
    Neuro Oncol; 2016 Nov; 18(11):1519-1528. PubMed ID: 27370397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of non-canonical NF-κB signaling as a critical mediator of Smac mimetic-stimulated migration and invasion of glioblastoma cells.
    Tchoghandjian A; Jennewein C; Eckhardt I; Rajalingam K; Fulda S
    Cell Death Dis; 2013 Mar; 4(3):e564. PubMed ID: 23538445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PARP inhibitor cyanine dye conjugate with enhanced cytotoxic and antiproliferative activity in patient derived glioblastoma cell lines.
    Choi PJ; Cooper E; Schweder P; Mee E; Turner C; Faull R; Denny WA; Dragunow M; Park TI; Jose J
    Bioorg Med Chem Lett; 2020 Jul; 30(14):127252. PubMed ID: 32527552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of Rb and mTOR signaling associates with synergistic anticancer effect of palbociclib and erlotinib in glioblastoma cells.
    Liu S; Tang Y; Yuan X; Yuan D; Liu J; Li B; Li Y
    Invest New Drugs; 2018 Dec; 36(6):961-969. PubMed ID: 29508248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conjugation of Dasatinib with MHI-148 Has a Significant Advantageous Effect in Viability Assays for Glioblastoma Cells.
    Usama SM; Jiang Z; Pflug K; Sitcheran R; Burgess K
    ChemMedChem; 2019 Sep; 14(17):1575-1579. PubMed ID: 31322832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ultraviolet-irradiation-induced apoptosis is mediated via ligand independent activation of tumor necrosis factor receptor 1.
    Sheikh MS; Antinore MJ; Huang Y; Fornace AJ
    Oncogene; 1998 Nov; 17(20):2555-63. PubMed ID: 9840918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GBM Derived Gangliosides Induce T Cell Apoptosis through Activation of the Caspase Cascade Involving Both the Extrinsic and the Intrinsic Pathway.
    Mahata B; Biswas S; Rayman P; Chahlavi A; Ko J; Bhattacharjee A; Li YT; Li Y; Das T; Sa G; Raychaudhuri B; Vogelbaum MA; Tannenbaum C; Finke JH; Biswas K
    PLoS One; 2015; 10(7):e0134425. PubMed ID: 26226135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. X-linked inhibitor regulating TRAIL-induced apoptosis in chemoresistant human primary glioblastoma cells.
    Roa WH; Chen H; Fulton D; Gulavita S; Shaw A; Th'ng J; Farr-Jones M; Moore R; Petruk K
    Clin Invest Med; 2003 Oct; 26(5):231-42. PubMed ID: 14596484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ebselen sensitizes glioblastoma cells to Tumor Necrosis Factor (TNFalpha)-induced apoptosis through two distinct pathways involving NF-kappaB downregulation and Fas-mediated formation of death inducing signaling complex.
    Sharma V; Tewari R; Sk UH; Joseph C; Sen E
    Int J Cancer; 2008 Nov; 123(9):2204-12. PubMed ID: 18709644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulating lncRNA SNHG15/CDK6/miR-627 circuit by palbociclib, overcomes temozolomide resistance and reduces M2-polarization of glioma associated microglia in glioblastoma multiforme.
    Li Z; Zhang J; Zheng H; Li C; Xiong J; Wang W; Bao H; Jin H; Liang P
    J Exp Clin Cancer Res; 2019 Aug; 38(1):380. PubMed ID: 31462285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ST6Gal-I sialyltransferase promotes tumor necrosis factor (TNF)-mediated cancer cell survival via sialylation of the TNF receptor 1 (TNFR1) death receptor.
    Holdbrooks AT; Britain CM; Bellis SL
    J Biol Chem; 2018 Feb; 293(5):1610-1622. PubMed ID: 29233887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Direct involvement of the receptor-mediated apoptotic pathways in cisplatin-induced renal tubular cell death.
    Tsuruya K; Ninomiya T; Tokumoto M; Hirakawa M; Masutani K; Taniguchi M; Fukuda K; Kanai H; Kishihara K; Hirakata H; Iida M
    Kidney Int; 2003 Jan; 63(1):72-82. PubMed ID: 12472770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Palbociclib enhances activin-SMAD-induced cytostasis in estrogen receptor-positive breast cancer.
    Harada M; Morikawa M; Ozawa T; Kobayashi M; Tamura Y; Takahashi K; Tanabe M; Tada K; Seto Y; Miyazono K; Koinuma D
    Cancer Sci; 2019 Jan; 110(1):209-220. PubMed ID: 30343527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase-2 trial of palbociclib in adult patients with recurrent RB1-positive glioblastoma.
    Taylor JW; Parikh M; Phillips JJ; James CD; Molinaro AM; Butowski NA; Clarke JL; Oberheim-Bush NA; Chang SM; Berger MS; Prados M
    J Neurooncol; 2018 Nov; 140(2):477-483. PubMed ID: 30151703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of tumor necrosis factor alpha-mediated NFkappaB activation and leukocyte adhesion, with enhanced endothelial apoptosis, by G protein-linked receptor (TP) ligands.
    Ashton AW; Ware GM; Kaul DK; Ware JA
    J Biol Chem; 2003 Apr; 278(14):11858-66. PubMed ID: 12517920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.